The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐
like peptide‐1 (GLP‐1) have their main physiological role in augmenting insulin secretion …

Adipose tissue plays essential roles in maintaining lipid and glucose homeostasis. To date
several types of adipose tissue have been identified, namely white, brown, and beige, that …

Abstract Glucagon-like peptide-1 (GLP-1) is produced in gut endocrine cells and in the
brain, and acts through hormonal and neural pathways to regulate islet function, satiety, and …

Therapeutic strategies for neurodegenerative disorders have commonly targeted individual
aspects of the disease pathogenesis to little success. Neurodegenerative diseases …

Obesity and its complications—including type 2 diabetes, cardiovascular disease, and
certain cancers—constitute a rising global epidemic that has imposed a substantial burden …

Glucagon-like peptide-1 is a peptide of incretin family which is used in the management of
diabetes as glucagon-like peptide-1 receptor agonist (GLP-1RA). Dipeptidyl peptidase-4 …

Purpose Polycystic ovary syndrome (PCOS) is a complex genetic trait and the most common
endocrine disorder of women, clinically evident in 5% to 15% of reproductive-aged women …

The glucagon-like peptide-1 (GLP-1) is a pleiotropic hormone well known for its incretin
effect in the glucose-dependent stimulation of insulin secretion. However, GLP-1 is also …

Glucagon like-peptide 1 (GLP-1) within the brain is produced by a population of
preproglucagon neurons located in the caudal nucleus of the solitary tract. These neurons …

We aim to investigate the expression of the glucagon receptor (GCGR) in human adipose
tissue, and the impact of glucagon in glucose uptake and lipolysis in human adipocytes …